EFFICACY OF TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA IN TERMS OF TRIAL WITHOUT CATHETER, A RANDOMIZED CONTROL TRIAL

BACKGROUND & OBJECTIVE: Benign prostatic hyperplasia (BPH) is a prevalent cause of voiding problems in older males and is most commonly associated with acute urological complications, most important of which is acute urinary retention (AUR). α1- antagonists are the treatment of choice for the ma...

Full description

Bibliographic Details
Main Authors: Farhan Khan, Usman Qamar, Muhammad Saifullah, Muhammad Sheraz Javed, Ahsan Ali Arain, Muhammad Sohail, Murli Lal
Format: Article
Language:English
Published: University of Faisalabad 2021-08-01
Series:Journal of University Medical & Dental College
Subjects:
Online Access:http://www.jumdc.com/index.php/jumdc/article/view/558
_version_ 1823989089889681408
author Farhan Khan
Usman Qamar
Muhammad Saifullah
Muhammad Sheraz Javed
Ahsan Ali Arain
Muhammad Sohail
Murli Lal
author_facet Farhan Khan
Usman Qamar
Muhammad Saifullah
Muhammad Sheraz Javed
Ahsan Ali Arain
Muhammad Sohail
Murli Lal
author_sort Farhan Khan
collection DOAJ
description BACKGROUND & OBJECTIVE: Benign prostatic hyperplasia (BPH) is a prevalent cause of voiding problems in older males and is most commonly associated with acute urological complications, most important of which is acute urinary retention (AUR). α1- antagonists are the treatment of choice for the management of patients with BPH. Our objective was to evaluate the efficacy of tamsulosin for the treatment of patients with AUR due to BPH in terms of trial without catheter (TWOC). METHODOLOGY: This randomized control trial was conducted in a Urology Section, Department of Surgery, SIUT Karachi, from 21-12-2016 to 20-06-2017. Our study included 136 patients who presented AUR due to BPH as per selection criteria. Patients were randomized into two groups. Group A patients received tamsulosin (0.4 mg), and group B patients received placebo drug immediately after insertion of Foley catheter. The success of TWOC was evaluated after 3 days of medical treatment. Statistical analysis was carried out using SPSS v20.0. RESULTS: The mean age of the study patients was 59.45 + 8.05 years. The mean duration of BPH disease was 15.39 + 6.84 months. There were 33 (48.5%) patients in the tamsulosin group in which TWOC was successful and only 22 (32.4%) patients in placebo group in which TWOC was successful (p-value 0.04). There was no effect of age and duration of BPH disease on the outcome of this study. CONCLUSION: Tamsulosin is effective for the treatment of patients with AUR due to BPH.
first_indexed 2024-12-18T13:53:17Z
format Article
id doaj.art-dcb4362da64d42a48d6cf079ae75e34a
institution Directory Open Access Journal
issn 2221-7827
2310-5542
language English
last_indexed 2024-12-18T13:53:17Z
publishDate 2021-08-01
publisher University of Faisalabad
record_format Article
series Journal of University Medical & Dental College
spelling doaj.art-dcb4362da64d42a48d6cf079ae75e34a2022-12-21T21:05:32ZengUniversity of FaisalabadJournal of University Medical & Dental College2221-78272310-55422021-08-0112310.37723/jumdc.v12i3.558EFFICACY OF TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA IN TERMS OF TRIAL WITHOUT CATHETER, A RANDOMIZED CONTROL TRIALFarhan Khan0Usman Qamar1Muhammad Saifullah2Muhammad Sheraz Javed3Ahsan Ali Arain4Muhammad Sohail5Murli Lal6Lecturer, Department of Urology Sindh Institute of Urology and Transplantation, Karachi.Lecturer, Department of Urology Sindh Institute of Urology and Transplantation, Karachi.Senior Registrar, Department of Urology, District Head Quarter Hospital / Faisalabad Medical University.Senior Registrar, Department of Urology, District Head Quarter Hospital / Faisalabad Medical University.Registrar, Department of Urology, Liaquat University Hospital, Hyderabad / Jamshoro.Associate Professor, Department of Urology Aziz Fatima Medical and Dental College, Faisalabad.Professor Department of Urology, SIUT, Karachi.BACKGROUND & OBJECTIVE: Benign prostatic hyperplasia (BPH) is a prevalent cause of voiding problems in older males and is most commonly associated with acute urological complications, most important of which is acute urinary retention (AUR). α1- antagonists are the treatment of choice for the management of patients with BPH. Our objective was to evaluate the efficacy of tamsulosin for the treatment of patients with AUR due to BPH in terms of trial without catheter (TWOC). METHODOLOGY: This randomized control trial was conducted in a Urology Section, Department of Surgery, SIUT Karachi, from 21-12-2016 to 20-06-2017. Our study included 136 patients who presented AUR due to BPH as per selection criteria. Patients were randomized into two groups. Group A patients received tamsulosin (0.4 mg), and group B patients received placebo drug immediately after insertion of Foley catheter. The success of TWOC was evaluated after 3 days of medical treatment. Statistical analysis was carried out using SPSS v20.0. RESULTS: The mean age of the study patients was 59.45 + 8.05 years. The mean duration of BPH disease was 15.39 + 6.84 months. There were 33 (48.5%) patients in the tamsulosin group in which TWOC was successful and only 22 (32.4%) patients in placebo group in which TWOC was successful (p-value 0.04). There was no effect of age and duration of BPH disease on the outcome of this study. CONCLUSION: Tamsulosin is effective for the treatment of patients with AUR due to BPH.http://www.jumdc.com/index.php/jumdc/article/view/558TamsulosinBenign Prostatic HyperplasiaUrinary Retention
spellingShingle Farhan Khan
Usman Qamar
Muhammad Saifullah
Muhammad Sheraz Javed
Ahsan Ali Arain
Muhammad Sohail
Murli Lal
EFFICACY OF TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA IN TERMS OF TRIAL WITHOUT CATHETER, A RANDOMIZED CONTROL TRIAL
Journal of University Medical & Dental College
Tamsulosin
Benign Prostatic Hyperplasia
Urinary Retention
title EFFICACY OF TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA IN TERMS OF TRIAL WITHOUT CATHETER, A RANDOMIZED CONTROL TRIAL
title_full EFFICACY OF TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA IN TERMS OF TRIAL WITHOUT CATHETER, A RANDOMIZED CONTROL TRIAL
title_fullStr EFFICACY OF TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA IN TERMS OF TRIAL WITHOUT CATHETER, A RANDOMIZED CONTROL TRIAL
title_full_unstemmed EFFICACY OF TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA IN TERMS OF TRIAL WITHOUT CATHETER, A RANDOMIZED CONTROL TRIAL
title_short EFFICACY OF TAMSULOSIN IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA IN TERMS OF TRIAL WITHOUT CATHETER, A RANDOMIZED CONTROL TRIAL
title_sort efficacy of tamsulosin in patients with benign prostatic hyperplasia in terms of trial without catheter a randomized control trial
topic Tamsulosin
Benign Prostatic Hyperplasia
Urinary Retention
url http://www.jumdc.com/index.php/jumdc/article/view/558
work_keys_str_mv AT farhankhan efficacyoftamsulosininpatientswithbenignprostatichyperplasiaintermsoftrialwithoutcatheterarandomizedcontroltrial
AT usmanqamar efficacyoftamsulosininpatientswithbenignprostatichyperplasiaintermsoftrialwithoutcatheterarandomizedcontroltrial
AT muhammadsaifullah efficacyoftamsulosininpatientswithbenignprostatichyperplasiaintermsoftrialwithoutcatheterarandomizedcontroltrial
AT muhammadsherazjaved efficacyoftamsulosininpatientswithbenignprostatichyperplasiaintermsoftrialwithoutcatheterarandomizedcontroltrial
AT ahsanaliarain efficacyoftamsulosininpatientswithbenignprostatichyperplasiaintermsoftrialwithoutcatheterarandomizedcontroltrial
AT muhammadsohail efficacyoftamsulosininpatientswithbenignprostatichyperplasiaintermsoftrialwithoutcatheterarandomizedcontroltrial
AT murlilal efficacyoftamsulosininpatientswithbenignprostatichyperplasiaintermsoftrialwithoutcatheterarandomizedcontroltrial